Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Summary:
- MACD is crossing MACD signal line at 0.3. MACD crossing signal line is bullish signal.
| MarketCap | 109.8B |
|---|---|
| PE Ratio | 19.7 |
| PEG Ratio | 1.9 |
| P/B | 5.2 |
| P/S (ttm) | 1.4 |
| Earning Growth (QoQ) | -63% |
| Revenue Growth (QoQ) | |
| Short % | 3% |
| Held by Institutions % | 59% |
| 1 Day Vol Adjusted Return | 1.6 |
| 1 Month Vol Adjusted Return | 2.2 |
| 3 Month Vol Adjusted Return | -0.8 |
| 6 Month Vol Adjusted Return | -2.3 |
| 20 Days SMA Price ZScore | 1.3 |
| 50 Days SMA Price ZScore | -0.1 |
| 12 -26 Days PPO | -0.3 |
| 1 Month Average Short Volume Ratio | 32.5 |
| 1 Day Volume Change ZScore | 0.8 |
| 1 Month Daily Vol | 1.4 |
Stock news
While international governments are rolling out credentialing systems designed for their citizens to prove they’ve been inoculated against COVID-19, the concept of a government-mandated “vaccine passport” could be a non-starter in the U.S., due to legal and, perhaps more so, pragmatic barriers.
(Bloomberg) -- Microsoft Corp. is in danger of losing a contract to provide $10 billion of cloud computing services to the Pentagon, a deal the government has threatened to scrap altogether after years of legal squabbling.The U.S. Defense Department said it will reconsider the controversial procurement if a federal judge declines to dismiss Amazon.com Inc.’s allegations that former President Donald Trump’s meddling cost the company the winner-take-all contract. That means the fate of a cloud pro...
Moderna Inc. (NASDAQ: MRNA) and International Business Machines Corp. (NYSE: IBM) plan to collaborate on technologies that could help support smarter management of COVID-19 vaccines, including improving supply chain management and real-time tracking of vaccines. What Happened: The companies said Thursday they will focus on technologies such as artificial intelligence, blockchain and hybrid cloud to help improve information sharing among governments and health care providers to address potential ...
Today, Moderna (Nasdaq: MRNA) and IBM (NYSE: IBM) announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management. Central to the effort will be a pilot of open, standardized, technology-enabled vaccine distribution approaches aimed to improve supply chain visibility and foster near real-time tracking of vaccine administration.
International Business Machines (IBM) recently announced that IBM Cloud Satellite will render its hybrid cloud services generally available across all environments.
Moderna and IBM will 'explore technologies, including AI, blockchain and hybrid cloud' to improve vaccine management.
International Business Machines (NYSE: IBM) has redefined itself since Arvind Krishna became CEO in April. Looking to align the company with the current tech environment, IBM spent $34 billion to buy cloud giant Red Hat in 2019. Krishna, who headed IBM's cloud and cognitive software division at that time, spearheaded this acquisition.
Zacks Market Edge Highlights: Square, CBOE Global Markets, Accenture and IBM
(Bloomberg) -- The Nasdaq 100 Index has taken a nasty dip in recent weeks but some tech stocks are rallying -- just not the ones that have ridden on the waves of investor euphoria in recent years.Older technology companies peddling legacy products have rallied in the past two weeks as rising bond yields and an improving economy have prompted investors to sell shares of faster-growing companies like Salesforce.com and buy more profitable ones like HP Inc.HP, Xerox Holdings Corp. and Oracle Corp. ...